Publisher: Karger
E-ISSN: 1664-5529|1|1|262-271
ISSN: 1664-5529
Source: Nephron Extra, Vol.1, Iss.1, 2011-12, pp. : 262-271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Depression is a prevalent burden for patients with end-stage renal disease (ESRD) and one that is under-recognized and consequently under-treated. Although several studies have explored the association between depression symptoms, treatment adherence and outcomes in Euro-American patient groups, quantitative and qualitative exploration of these issues in patients from different cultural and ethnic backgrounds has been lacking. This review discusses the methodological issues associated with measuring depression in patients of South Asian origin who have a 3- to 5-fold greater risk of developing ESRD. There is a need to advance research into the development of accurate screening practices for this patient group, with an emphasis on studies utilizing rigorous approaches to evaluating the use of both emic (culture-specific) and etic (universal or culture-general) screening instruments.
Related content
Keloids and End-Stage Renal Disease
Nephron, Vol. 80, Iss. 2, 1998-09 ,pp. :
Vitamin K Antagonists Predispose to Calciphylaxis in Patients with End-Stage Renal Disease
Nephron, Vol. 129, Iss. 3, 2015-02 ,pp. :
Arterial Stiffness and Walk Time in Patients with End-Stage Renal Disease
Kidney and Blood Pressure Research, Vol. 37, Iss. 2-3, 2013-04 ,pp. :
Serum Levels of Omentin in End-Stage Renal Disease Patients
Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-07 ,pp. :
Chronic Inflammation and Coronary Atherosclerosis in Patients with End-Stage Renal Disease
Cardiorenal Medicine, Vol. 2, Iss. 2, 2012-03 ,pp. :